Balo Andrew K
Officer at DXCM
- Sold, on record
- $69.8M
- Dollars the filings state
- Form 4 sales
- 100
- Latest Sep 9, 2021
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DXCMDEXCOM INCOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale DXCMPlan not statedSep 15, 2020 2020
Sold 5,256 shares at $397.35 ($2.1M)
Sold 12.9% of holdings ($16.2M position)35,567 shares left0.9x usual sizeFiling
- 2 Form 4 sale DXCMPlan not statedMar 10, 2021 +176 days
Sold 5,566 shares at $362.92 ($2M)
Sold 13.6% of holdings ($14.8M position)35,307 shares left0.8x usual sizeFiling
- 3 Form 4 sale DXCMPlan not statedJun 3, 2021 +85 days
Sold 2,391 shares at $375.00 ($897k)
Sold 12.7% of holdings ($7M position)16,383 shares left0.4x usual sizeFiling
- 4 Form 4 sale DXCMPlan not statedJul 6, 2021 +33 days
Sold 2,974 shares at $430.14 ($1.3M)
Sold 18.2% of holdings ($7M position)13,409 shares left0.5x usual sizeFiling
- 5 Form 4 sale DXCMPlan not statedAug 3, 2021 +28 days
Sold 2,757 shares at $515.87 ($1.4M)
Sold 20.6% of holdings ($6.9M position)10,652 shares left0.5x usual sizeFiling
- 6 Form 4 sale DXCMUnusualSep 9, 2021 +37 days
Sold 5,597 shares at $546.78 ($3.1M)
Sold 42.6% of holdings ($7.2M position)7,553 shares left1.1x usual sizeFiling
- 7 Form 144 notice DXCMNoticeJun 15, 2023 +644 days
Filed to sell 4,940 shares ($642k)
Balo Andrew K, Officer
10b5-1 plan1.7x usual sizeFiling
- 8 Form 144 notice DXCMNoticeJul 14, 2023 +29 days
Filed to sell 4,956 shares ($669k)
Balo Andrew K, Officer
10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (102)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2023 | Jul 14, 2023 | DXCM | Officer | Form 144 notice | 4,956 | $669k | Notice | SEC | |
| Jun 15, 2023 | Jun 15, 2023 | DXCM | Officer | Form 144 notice | 4,940 | $642k | Notice | SEC | |
| Sep 9, 2021 | Sep 13, 2021 | DXCM | * | Form 4 sale | 5,597 | $3.1M | 42.6% | Unusual | SEC |
| Aug 3, 2021 | Aug 4, 2021 | DXCM | * | Form 4 sale | 2,757 | $1.4M | 20.6% | Plan not stated | SEC |
| Jul 6, 2021 | Jul 8, 2021 | DXCM | * | Form 4 sale | 2,974 | $1.3M | 18.2% | Plan not stated | SEC |
| Jun 3, 2021 | Jun 7, 2021 | DXCM | * | Form 4 sale | 2,391 | $897k | 12.7% | Plan not stated | SEC |
| Mar 10, 2021 | Mar 12, 2021 | DXCM | * | Form 4 sale | 5,566 | $2M | 13.6% | Plan not stated | SEC |
| Sep 15, 2020 | Sep 16, 2020 | DXCM | * | Form 4 sale | 5,256 | $2.1M | 12.9% | Plan not stated | SEC |
| Sep 9, 2020 | Sep 11, 2020 | DXCM | * | Form 4 sale | 4,580 | $1.8M | 10.1% | Plan not stated | SEC |
| Jun 15, 2020 | Jun 17, 2020 | DXCM | * | Form 4 sale | 6,522 | $2.4M | 12.6% | Plan not stated | SEC |
| Apr 15, 2020 | Apr 17, 2020 | DXCM | * | Form 4 sale | 6,690 | $1.9M | 11.4% | Plan not stated | SEC |
| Mar 11, 2020 | Mar 13, 2020 | DXCM | * | Form 4 sale | 8,161 | $2.2M | 12.2% | Plan not stated | SEC |
| Sep 18, 2019 | Sep 19, 2019 | DXCM | * | Form 4 sale | 2,386 | $361k | 4.0% | Plan not stated | SEC |
| Sep 9, 2019 | Sep 11, 2019 | DXCM | * | Form 4 sale | 9,107 | $1.4M | 13.1% | Plan not stated | SEC |
| Sep 3, 2019 | Sep 5, 2019 | DXCM | * | Form 4 sale | 37 | $6k | 0.1% | Plan not stated | SEC |
| Jun 5, 2019 | Jun 6, 2019 | DXCM | * | Form 4 sale | 7,825 | $978k | 10.1% | Plan not stated | SEC |
| Mar 12, 2019 | Mar 13, 2019 | DXCM | * | Form 4 sale | 10,917 | $1.6M | 12.4% | Plan not stated | SEC |
| Dec 14, 2018 | Dec 18, 2018 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 5,000 | $606k | 6.4% | Plan not stated | SEC |
| Nov 14, 2018 | Nov 16, 2018 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 5,000 | $716k | 6.0% | Plan not stated | SEC |
| Oct 12, 2018 | Oct 16, 2018 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 5,000 | $624k | 5.7% | Plan not stated | SEC |
| Sep 14, 2018 | Sep 18, 2018 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 5,000 | $726k | 5.4% | Plan not stated | SEC |
| Sep 10, 2018 | Sep 12, 2018 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 5,587 | $803k | 5.7% | Plan not stated | SEC |
| Aug 14, 2018 | Aug 16, 2018 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 5,000 | $621k | 4.8% | Plan not stated | SEC |
| Jul 16, 2018 | Jul 18, 2018 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 5,000 | $498k | 4.6% | Plan not stated | SEC |
| Dec 11, 2017 | Dec 13, 2017 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 3,245 | $199k | 3.9% | Plan not stated | SEC |
| Nov 29, 2017 | Nov 30, 2017 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 6,490 | $389k | 7.3% | Plan not stated | SEC |
| Sep 11, 2017 | Sep 13, 2017 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 3,244 | $234k | 3.2% | Plan not stated | SEC |
| Aug 10, 2017 | Aug 11, 2017 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 3,244 | $231k | 3.1% | Plan not stated | SEC |
| Jul 10, 2017 | Jul 12, 2017 | DXCM | EVP, Reg. Strategy, Clinical | Form 4 sale | 3,200 | $229k | 3.0% | Plan not stated | SEC |
| Jun 12, 2017 | Jun 13, 2017 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 3,200 | $221k | 2.9% | Plan not stated | SEC |
| May 10, 2017 | May 12, 2017 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 3,200 | $230k | 2.8% | Plan not stated | SEC |
| Apr 10, 2017 | Apr 12, 2017 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 3,200 | $250k | 2.8% | Plan not stated | SEC |
| Mar 10, 2017 | Mar 14, 2017 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 3,200 | $249k | 2.4% | Plan not stated | SEC |
| Feb 10, 2017 | Feb 14, 2017 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 3,200 | $254k | 3.0% | Plan not stated | SEC |
| Jan 10, 2017 | Jan 12, 2017 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 3,200 | $201k | 2.9% | Plan not stated | SEC |
| Oct 19, 2016 | Oct 20, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 4,997 | $411k | 4.5% | Plan not stated | SEC |
| Oct 5, 2016 | Oct 7, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 5,000 | $413k | 4.3% | Plan not stated | SEC |
| Sep 21, 2016 | Sep 22, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 5,000 | $464k | 4.1% | Plan not stated | SEC |
| Sep 7, 2016 | Sep 9, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 4,999 | $472k | 3.7% | Plan not stated | SEC |
| Aug 24, 2016 | Aug 26, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 5,000 | $459k | 3.7% | Plan not stated | SEC |
| Aug 10, 2016 | Aug 12, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 5,000 | $451k | 3.7% | Plan not stated | SEC |
| Jul 27, 2016 | Jul 28, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 5,000 | $441k | 3.7% | Plan not stated | SEC |
| Jul 13, 2016 | Jul 14, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 5,000 | $401k | 3.7% | Plan not stated | SEC |
| Jun 29, 2016 | Jul 1, 2016 | DXCM | EVP, Clinical and Regulatory | Form 4 sale | 5,000 | $391k | 3.7% | Plan not stated | SEC |
| Jun 20, 2016 | Jun 20, 2016 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 55,000 | $4.1M | 29.7% | Unusual | SEC |
| Dec 17, 2015 | Dec 21, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $619k | 6.5% | Plan not stated | SEC |
| Dec 3, 2015 | Dec 4, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $648k | 6.5% | Plan not stated | SEC |
| Nov 25, 2015 | Nov 30, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $656k | 6.5% | Plan not stated | SEC |
| Nov 24, 2015 | Nov 24, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 10,000 | $864k | 8.1% | Plan not stated | SEC |
| Nov 11, 2015 | Nov 12, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $634k | 6.2% | Plan not stated | SEC |
| Oct 20, 2015 | Oct 21, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 4,538 | $370k | 3.9% | Plan not stated | SEC |
| Oct 6, 2015 | Oct 7, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 8,216 | $676k | 6.5% | Plan not stated | SEC |
| Sep 21, 2015 | Sep 22, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,859 | $792k | 5.9% | Plan not stated | SEC |
| Sep 8, 2015 | Sep 9, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $671k | 5.0% | Plan not stated | SEC |
| Aug 20, 2015 | Aug 24, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $694k | 4.8% | Plan not stated | SEC |
| Aug 6, 2015 | Aug 10, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $713k | 4.5% | Plan not stated | SEC |
| Jul 22, 2015 | Jul 24, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 10,214 | $866k | 5.8% | Plan not stated | SEC |
| Jul 8, 2015 | Jul 9, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 4,494 | $361k | 2.5% | Plan not stated | SEC |
| Jun 23, 2015 | Jun 25, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 5,573 | $432k | 3.0% | Plan not stated | SEC |
| Jun 9, 2015 | Jun 11, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $530k | 4.0% | Plan not stated | SEC |
| May 18, 2015 | May 20, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $513k | 4.0% | Plan not stated | SEC |
| May 4, 2015 | May 5, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $510k | 4.0% | Plan not stated | SEC |
| Apr 23, 2015 | Apr 27, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $522k | 4.0% | Plan not stated | SEC |
| Apr 9, 2015 | Apr 10, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $484k | 4.0% | Plan not stated | SEC |
| Mar 25, 2015 | Mar 27, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $458k | 4.0% | Plan not stated | SEC |
| Mar 11, 2015 | Mar 13, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $439k | 3.9% | Plan not stated | SEC |
| Feb 24, 2015 | Feb 26, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $467k | 4.8% | Plan not stated | SEC |
| Feb 10, 2015 | Feb 12, 2015 | DXCM | EVP, Clinical, Regulatory | Form 4 sale | 7,500 | $461k | 4.8% | Plan not stated | SEC |
| Jan 26, 2015 | Jan 28, 2015 | DXCM | EVP, Clinical, Regulatory & | Form 4 sale | 15,001 | $889k | 9.1% | Plan not stated | SEC |
| Dec 26, 2014 | Dec 30, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $553k | 6.2% | Plan not stated | SEC |
| Dec 11, 2014 | Dec 15, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $554k | 6.2% | Plan not stated | SEC |
| Nov 25, 2014 | Nov 26, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $511k | 6.2% | Plan not stated | SEC |
| Nov 11, 2014 | Nov 13, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $529k | 6.2% | Plan not stated | SEC |
| Oct 27, 2014 | Oct 28, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $430k | 6.2% | Plan not stated | SEC |
| Oct 13, 2014 | Oct 14, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $404k | 6.2% | Plan not stated | SEC |
| Sep 25, 2014 | Sep 25, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $407k | 6.2% | Plan not stated | SEC |
| Sep 11, 2014 | Sep 12, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $430k | 6.1% | Plan not stated | SEC |
| Aug 25, 2014 | Aug 27, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $441k | 5.9% | Plan not stated | SEC |
| Aug 22, 2014 | Aug 25, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 20,000 | $885k | 11.2% | Plan not stated | SEC |
| Aug 11, 2014 | Aug 12, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $442k | 5.9% | Plan not stated | SEC |
| Jul 25, 2014 | Jul 29, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $382k | 5.9% | Plan not stated | SEC |
| Jul 11, 2014 | Jul 15, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $359k | 5.9% | Plan not stated | SEC |
| Jun 25, 2014 | Jun 25, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $406k | 5.9% | Plan not stated | SEC |
| Jun 11, 2014 | Jun 13, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $366k | 5.9% | Plan not stated | SEC |
| May 27, 2014 | May 28, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $339k | 5.9% | Plan not stated | SEC |
| May 12, 2014 | May 14, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $318k | 5.9% | Plan not stated | SEC |
| Apr 25, 2014 | Apr 29, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $344k | 5.9% | Plan not stated | SEC |
| Apr 11, 2014 | Apr 15, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $354k | 5.9% | Plan not stated | SEC |
| Mar 25, 2014 | Mar 26, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $430k | 5.9% | Plan not stated | SEC |
| Mar 11, 2014 | Mar 13, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $459k | 5.6% | Plan not stated | SEC |
| Feb 25, 2014 | Feb 27, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $450k | 7.4% | Plan not stated | SEC |
| Feb 11, 2014 | Feb 13, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $395k | 7.4% | Plan not stated | SEC |
| Jan 27, 2014 | Jan 29, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $367k | 7.4% | Plan not stated | SEC |
| Jan 13, 2014 | Jan 15, 2014 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $374k | 7.4% | Plan not stated | SEC |
| Dec 3, 2013 | Dec 4, 2013 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 14,268 | $488k | 10.3% | Plan not stated | SEC |
| Nov 12, 2013 | Nov 13, 2013 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 42,222 | $1.4M | 23.4% | Plan not stated | SEC |
| Jun 13, 2013 | Jun 17, 2013 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 10,000 | $219k | 6.5% | Plan not stated | SEC |
| May 13, 2013 | May 13, 2013 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 45,000 | $873k | 23.7% | Unusual | SEC |
| Mar 13, 2013 | Mar 13, 2013 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 15,416 | $255k | 9.6% | Plan not stated | SEC |
| Dec 13, 2012 | Dec 14, 2012 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 12,760 | $178k | 10.9% | Plan not stated | SEC |
| May 18, 2012 | May 22, 2012 | DXCM | SVP, Regulatory and Clinical | Form 4 sale | 14,198 | $149k | 11.2% | Plan not stated | SEC |
| May 2, 2006 | May 4, 2006 | DXCM | VP of Clinical & Regulatory | Form 4 sale | 100,000 | $2.4M | 99.1% | Unusual | SEC |